Transcription factor AP-2 alpha (TFAP2A) and Early B-Cell Factor 2 (EBF2) were identified as epigenetic molecular markers in Acute lymphoblastic leukemia (ALL) and CML-BP. This evidence concerns the gene TFAP2A and acute lymphoblastic leukemia.